Genmab A/S

Genmab is a Danish biotech company specializing in the development of innovative antibody-based therapeutics for cancer and other diseases. Since its inception in 1999, the company has established itself as a pioneer in the biotech sector by prioritizing research and development.

The company's pharmaceutical pipeline includes a number of cutting-edge cancer therapies, such as monoclonal antibodies and bispecific antibodies. Furthermore, Genmab is committed to developing new platforms and technologies for the discovery and development of innovative treatments.

Genmab's success can be attributed to its devotion to innovation as well as its emphasis on quality and perfection. The company employs a strong team of scientists and researchers who work tirelessly to promote biotechnology and improve the lives of patients.

Genmab is one of Europe's largest and most recognized biotech enterprises, with a global reach and a reputation for quality. Whether you are a researcher, doctor, or other professional in the biotech business, Genmab is a name you can trust for cutting-edge solutions and unparalleled service.

Founded: 1999

Headquarters: Copenhagen, Denmark

Website: https://www.genmab.com/